321 related articles for article (PubMed ID: 16908513)
1. Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system.
Hori H; Ajiki T; Fujita T; Okazaki T; Suzuki Y; Kuroda Y; Fujimori T
Jpn J Clin Oncol; 2006 Oct; 36(10):638-42. PubMed ID: 16908513
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
3. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
4. Double cancer of the gallbladder and common bile duct associated with anomalous junction of pancreaticobiliary ductal system.
Ikoma A; Nakamura N; Miyazaki T; Maeda M
Surgery; 1992 May; 111(5):595-600. PubMed ID: 1598682
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
7. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
8. Double cancer of gallbladder and bile duct associated with anomalous junction of the pancreaticobiliary ductal system.
Takayashiki T; Miyazaki M; Kato A; Ito H; Nakagawa K; Ambiru S; Shimizu H; Furuya S; Nakajima N
Hepatogastroenterology; 2002; 49(43):109-12. PubMed ID: 11941931
[TBL] [Abstract][Full Text] [Related]
9. [A case of synchronous cancer of the gall bladder, common bile duct, and the papilla of vater].
Ueno G; Ishikawa S; Ichikawa Y; Hagi T; Taniura N; Chong H; Kanazawa A; Takayama S; Nishihara M; Maruyama K; Shimada M; Lee K; Oka H; Maeda T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1521-3. PubMed ID: 25731239
[TBL] [Abstract][Full Text] [Related]
10. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
11. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Zhi LZ; Miura H; Ochiai M; Funabiki T
J Hepatobiliary Pancreat Surg; 2002; 9(3):312-21. PubMed ID: 12353142
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
13. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
[TBL] [Abstract][Full Text] [Related]
14. Sex-based differences in gallbladder cancer associated with pancreaticobiliary maljunction.
Kamisawa T; Munakata W; Tu Y; Egawa N; Tsuruta K; Okamoto A
Hepatogastroenterology; 2008; 55(81):21-3. PubMed ID: 18507071
[TBL] [Abstract][Full Text] [Related]
15. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
[TBL] [Abstract][Full Text] [Related]
16. Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer.
Elnemr A; Ohta T; Kayahara M; Kitagawa H; Yoshimoto K; Tani T; Shimizu K; Nishimura G; Terada T; Miwa K
Hepatogastroenterology; 2001; 48(38):382-6. PubMed ID: 11379314
[TBL] [Abstract][Full Text] [Related]
17. Pancreas divisum in pancreaticobiliary maljunction.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2008; 55(81):249-53. PubMed ID: 18507118
[TBL] [Abstract][Full Text] [Related]
18. Relationship between types of common channel and development of biliary tract cancer in pancreaticobiliary maljunction.
Hara H; Morita S; Sako S; Dohi T; Otani M; Iwamoto M; Inoue H; Tanigawa N
Hepatogastroenterology; 2002; 49(44):322-5. PubMed ID: 11995442
[TBL] [Abstract][Full Text] [Related]
19. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
[TBL] [Abstract][Full Text] [Related]
20. Multiple Cancers of the Biliary Tract and Pancreatic Duct after Cholecystectomy for Gallbladder Cancer in a Patient with Pancreaticobiliary Maljunction.
Koizumi K; Sasajima J; Kawamoto T; Sugiyama Y; Muto M; Muto M; Ishikawa C; Inoue M; Kohgo Y
Intern Med; 2016; 55(2):141-6. PubMed ID: 26781013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
